Women's Health

New FDA guidance sharpens postmarket pregnancy drug safety data, improving labels and empowering pharmacists to report adverse events.

In this episode, Natalie DiPietro Mager, PharmD, PhD, meets with Sarah Chew, MPH, to discuss the pharmacist’s role in advancing women’s health research.

With continued pressure for federal action regarding the abortion drug mifepristone, SCOTUS blocked a previous decision that would limit the pill’s access.

In a recent research letter, investigators establish how removal of in-person dispensing requirements impact mifepristone pharmacy access.

In this episode, Natalie DiPietro Mager, PharmD, PhD, meets with Kami Dixon, MD, MA, to discuss the racial disparities across women’s health in the US.

With persistent challenges in the arena of US maternal health care, researchers assess pharmacists’ knowledge, confidence, and perceived barriers in filling maternal health gaps.

As debates heat up between anti-abortion and pro-life advocates, the federal government places a hold on any action toward mifepristone’s approval.

New evidence links poor sleep and diabetes risk to widespread prenatal anxiety, urging pharmacists to support metabolic control and mental health.

In this episode, Natalie DiPietro Mager, PharmD, PhD, meets with Paul Weidle, PharmD, MPH, to discuss HIV care among women and girls.

Investigators used a large cohort of patients from Taiwan between 2004 and 2015 to determine the potential link between Tylenol use and childhood neurodevelopment.

US pharmacists can prescribe contraception through streamlined pharmacy care, expanding access; supporting maternity deserts; and improving women’s health.

Highlighting 'prone to abuse' and adverse effects as the driver of this bill, Senator Hawley aims to reverse an FDA decision made over 25 years ago.

Pharmacists can close the gap between recommendations and uptake for pregnant women.

In this episode, Natalie DiPietro Mager, PharmD, PhD, MPH, chats with Laney Poye, the director of marketing and communications at the Preeclampsia Foundation.

With expanding scopes of practice, there has never been a better time to introduce or expand clinical services that improve patient outcomes.

The decision removes risk statements regarding cardiovascular disease, breast cancer, and probable dementia from the boxed warning.

Inhaled Technosphere insulin revolutionizes diabetes management for children and pregnant women, addressing treatment adherence and psychological barriers effectively.

During the week of Roe v Wade’s 53rd anniversary, debates between pro-choice and pro-life groups are yet again reaching the national stage.

Natalie DiPietro Mager, PharmD, PhD, explores some of the policies that have bolstered maternal health care and what can still be done to further improve patient outcomes.

In this episode, Natalie DiPietro Mager, PharmD, PhD, MPH, meets with Kristen Sobota, PharmD, BCPS, BCGP, and Kelly Kroustos, PharmD, CDP, to discuss caring for elderly women.

Gestational diabetes significantly impacts postpartum cardiovascular health, especially in women over 35, highlighting the need for timely interventions.

Following approval in 2023, researchers address lessons learned from the coalition- and movement-driven efforts to approve the first OTC oral contraceptive pill.

From gaps in care to formulary challenges, Susan Thomas, RN, explains how her independent PBM is working with pharmacists to improve women’s health outcomes.

Susan Thomas, RN, CCO at LucyRx, explained the unique offerings from a newly introduced women’s health benefit program launched on January 1, 2026.

Pharmacists are transforming reproductive health care by expanding their roles in contraception and patient support, despite facing significant barriers.